Increased Death Risk Prompts Boxed Warning for Gout Drug

Doctors should avoid prescribing the popular gout drug Uloric (febuxostat) in favor of Zyloprim (allopurinol) since there is an increased risk of death associated with Uloric, according to an FDA warning.

The FDA says its review of a postmarket trial of 6,000 patients comparing Uloric to Zyloprim found that Uloric was associated with an increased risk of heart-related death, as well as deaths from other causes, compared to Zyloprim. The analysis showed that there were 15 deaths per 1,000 people from heart-related causes for those in Uloric compared to 11 per 1,000 on Zyloprim.

As a result, the agency is requiring that the drug’s label contain a “black box” warning – the FDA’s most severe – warning of this risk. The FDA added that Uloric should be reserved for patients who fail on or who can’t tolerate Zyloprim. This essentially relegated Uloric to a second-line treatment.

Last year, consumer advocacy group Public Citizen urged the FDA to pull Uloric from the market. Uloric is also known to cause joint and muscle pain, as well as nausea.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement